Yi‐Long Wu

Researcher Next ID · RN-005098

Researcher · Medicine

Chengdu, China

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Journal of Thoracic Oncology · 2016 · https://doi.org/10.1016/j.jtho.2015.09.009
Lung cancer: current therapies and new targeted treatments
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30958-8
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1214886
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70184-x
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0810699

No projects listed.